Inventor profile of:

Michael E. Silver

City:

Lake City, Michigan

Country:

United States

Published Applications:

56

Last publication date:

2026-02-26

Top Assignees for applications by Michael E. Silver

The entities that hold a legal rights for patent applications filed by inventor Silver Michael E.:

Recent patent applications by Silver Michael E.

Michael E. Silver from Lake City, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-02-26
US20260055056A1
Chemistry; metallurgy

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

#2 | 2025-05-22
US20250161258A1
Human necessities

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

#3 | 2025-05-22
US20250161257A1
Human necessities

METHOD OF TREATING SEPSIS

#4 | 2025-05-22
US20250161256A1
Human necessities

METHOD FOR TREATING INFECTIOUS DISEASES WITH ISOTHIOCYANATE FUNCTIONAL COMPOUNDS

#5 | 2025-04-24
US20250127750A1
Human necessities

ISOTHIOCYANATE FUNCTIONAL COMPOUNDS AUGMENTED WITH SECONDARY ANTINEOPLASTIC MEDICAMENTS AND ASSOCIATED METHODS FOR TREATING NEOPLASMS

#6 | 2025-04-24
US20250127749A1
Human necessities

METHOD FOR TREATING METASTATIC PROSTATE CANCER

#7 | 2024-08-22
US20240279169A9
Chemistry; metallurgy

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

#8 | 2023-10-26
US20230338324A1
Human necessities

Method for treating rheumatoid arthritis

#9 | 2023-10-12
US20230321027A1
Human necessities

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

#10 | 2023-08-24
US20230263763A1
Human necessities

Method for treating infectious diseases with isothiocyanate functional compounds

#11 | 2023-08-17
US20230255920A1
Human necessities

Method for treating metastatic prostate cancer

#12 | 2023-07-27
US20230233505A1
Human necessities

Method for Treating Psoriasis

#13 | 2023-06-01
US20230165827A1
Human necessities

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

#14 | 2023-04-13
US20230110036A1
Chemistry; metallurgy

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

#15 | 2022-12-08
US20220388954A1
Chemistry; metallurgy

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

#16 | 2022-04-07
US20220106268A9
Chemistry; metallurgy

Isothiocyanate functional surfactant and associated method of use

#17 | 2021-11-18
US20210355081A1
Chemistry; metallurgy

ISOTHIOCYANATE FUNCTIONAL SURFACTANT AND ASSOCIATED METHOD OF USE

#18 | 2021-08-12
US20210244702A1
Human necessities

Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use

#19 | 2021-08-12
US20210244701A1
Human necessities

Method for treating infectious diseases with isothiocyanate functional compounds

#20 | 2021-08-05
US20210236453A1
Human necessities

Method for treating rheumatoid arthritis

#21 | 2021-07-29
US20210228528A1
Human necessities

Method for treating metastatic prostate cancer

#22 | 2021-02-04
US20210030710A1
Human necessities

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

#23 | 2021-02-04
US20210030709A1
Human necessities

Method for treating psoriasis

#24 | 2021-01-28
US20210024463A1
Chemistry; metallurgy

Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms

#25 | 2021-01-21
US20210017130A1
Chemistry; metallurgy

Use of isothiocyanate functional surfactants as NRF2 inducers to treat epidermolysis bullosa simplex and related diseases

#26 | 2020-07-02
US20200206180A1
Human necessities

Inhibitors of macrophage migration inhibitory factor

#27 | 2020-07-02
US20200206179A1
Human necessities

Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer

#28 | 2020-06-11
US20200179324A1
Human necessities

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

#29 | 2020-06-04
US20200170989A1
Human necessities

Method for treating skin cancer

#30 | 2020-03-05
US20200069634A1
Human necessities

Method for treating infectious diseases with isothiocyanate functional compounds

#31 | 2020-02-27
US20200062702A1
Chemistry; metallurgy

Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms

#32 | 2020-02-27
US20200061016A1
Human necessities

Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use

#33 | 2020-02-06
US20200038360A1
Human necessities

Inhibitors of macrophage migration inhibitory factor

#34 | 2020-01-30
US20200030277A1
Human necessities

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

#35 | 2019-12-05
US20190365696A1
Human necessities

Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer

#36 | 2019-10-31
US20190330145A1
Chemistry; metallurgy

Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases

#37 | 2019-09-26
US20190292145A1
Chemistry; metallurgy

Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use

#38 | 2019-09-19
US20190284133A1
Chemistry; metallurgy

Isothiocyanate functional surfactant and associated method of use

#39 | 2019-04-18
US20190112263A1
Chemistry; metallurgy

Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases

#40 | 2019-04-18
US20190111018A1
Human necessities

Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms

#41 | 2018-11-01
US20180311202A1
Human necessities

Method for treating infectious diseases with isothiocyanate functional compounds

#42 | 2018-10-25
US20180303786A1
Human necessities

Inhibitors of macrophage migration inhibitory factor

#43 | 2018-10-25
US20180303785A1
Human necessities

Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer

#44 | 2018-10-11
US20180290972A1
Chemistry; metallurgy

Isothiocyanate functional surfactant and associated method of use

#45 | 2018-10-11
US20180289661A1
Human necessities

Method for treating skin cancer

#46 | 2018-09-13
US20180256532A1
Human necessities

Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use

#47 | 2018-06-14
US20180162811A1
Chemistry; metallurgy

Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms

#48 | 2018-04-12
US20180098958A1
Human necessities

Method for treating bladder cancer

#49 | 2018-02-15
US20180042885A1
Human necessities

Method for treating autism and other neurodevelopmental disorders

#50 | 2018-02-08
US20180037545A1
Chemistry; metallurgy

Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms

#51 | 2018-01-18
US20180016229A1
Chemistry; metallurgy

USE OF ISOTHIOCYANATE FUNCTIONAL SURFACTANTS AS NRF2 INDUCERS TO TREAT EPIDERMOLYSIS BULLOSA SIMPLEX AND RELATED DISEASES

#52 | 2017-10-12
US20170290794A1
Human necessities

Method for treating eczema

#53 | 2017-08-24
US20170239207A1
Human necessities

Method for treating skin cancer

#54 | 2017-06-29
US20170181996A1
Human necessities

Method for treating neurodegenerative diseases

#55 | 2017-06-08
US20170157026A1
Human necessities

USE OF HYDROPHILIC-RICH ALKYLMETHYLSILOXANE-DIMETHYLSILOXANE-POLYOXYALKYLENE COPOLYMERS AS EMULSIFIERS FOR THE PREPARATION OF COSMETIC O/W EMULSIONS OF IMPROVED AESTHETIC PROPERTIES AND MILDNESS

#56 | 2017-05-25
US20170143659A1
Human necessities

Method for treating bladder cancer

InventorID:

1882741 ⎘